These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11961131

  • 21. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W.
    J Med Chem; 2002 Oct 10; 45(21):4737-47. PubMed ID: 12361401
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach.
    Liaw CW, Grigoriadis DE, Lovenberg TW, De Souza EB, Maki RA.
    Mol Endocrinol; 1997 Jun 10; 11(7):980-5. PubMed ID: 9178757
    [Abstract] [Full Text] [Related]

  • 28. Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated.
    Perry SJ, Junger S, Kohout TA, Hoare SR, Struthers RS, Grigoriadis DE, Maki RA.
    J Biol Chem; 2005 Mar 25; 280(12):11560-8. PubMed ID: 15653688
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep 25; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 31. Design, synthesis and pharmacological characterization of new highly selective CRF(2) antagonists: development of 123I-K31440 as a potential SPECT ligand.
    Rühmann A, Chapman J, Higelin J, Butscha B, Dautzenberg FM.
    Peptides; 2002 Mar 25; 23(3):453-60. PubMed ID: 11835994
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
    Rühmann A, Bonk I, Lin CR, Rosenfeld MG, Spiess J.
    Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15264-9. PubMed ID: 9860957
    [Abstract] [Full Text] [Related]

  • 39. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
    Beyermann M, Fechner K, Furkert J, Krause E, Bienert M.
    J Med Chem; 1996 Aug 16; 39(17):3324-30. PubMed ID: 8765516
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.